Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maria J. Larrayoz"'
Autor:
Jose A. Martinez-Climent, Felipe Prosper, Oscar Yanes, Xabier Agirre, Maria D. Odero, Maria J. Moreno-Aliaga, Bruno Paiva, Alvaro Martinez-Baztan, Julen Oyarzabal, Ruben Pio, Puri Fortes, Celia Prior, Jiahuai Han, Alexandra Junza, Carlos Panizo, Maria J. Calasanz, Maria J. Larrayoz, Marta Fernandez-Galilea, Carmen Vicente, Jon Celay, Marta Larrayoz, Maria J. Garcia-Barchino, Vicente Fresquet
For millions of years, endogenous retroelements have remained transcriptionally silent within mammalian genomes by epigenetic mechanisms. Modern anticancer therapies targeting the epigenetic machinery awaken retroelement expression, inducing antivira
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fd38133a1d3d0fc69bfac72ef54132a
https://doi.org/10.1158/2159-8290.c.6549353.v1
https://doi.org/10.1158/2159-8290.c.6549353.v1
Autor:
Jose A. Martinez-Climent, Felipe Prosper, Oscar Yanes, Xabier Agirre, Maria D. Odero, Maria J. Moreno-Aliaga, Bruno Paiva, Alvaro Martinez-Baztan, Julen Oyarzabal, Ruben Pio, Puri Fortes, Celia Prior, Jiahuai Han, Alexandra Junza, Carlos Panizo, Maria J. Calasanz, Maria J. Larrayoz, Marta Fernandez-Galilea, Carmen Vicente, Jon Celay, Marta Larrayoz, Maria J. Garcia-Barchino, Vicente Fresquet
Supplementary Figures S1-S7 with legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04cd1ba7e34a4f91806bf9b7dfe5c665
https://doi.org/10.1158/2159-8290.22540328.v1
https://doi.org/10.1158/2159-8290.22540328.v1
Autor:
Jose A. Martinez-Climent, Felipe Prosper, Oscar Yanes, Xabier Agirre, Maria D. Odero, Maria J. Moreno-Aliaga, Bruno Paiva, Alvaro Martinez-Baztan, Julen Oyarzabal, Ruben Pio, Puri Fortes, Celia Prior, Jiahuai Han, Alexandra Junza, Carlos Panizo, Maria J. Calasanz, Maria J. Larrayoz, Marta Fernandez-Galilea, Carmen Vicente, Jon Celay, Marta Larrayoz, Maria J. Garcia-Barchino, Vicente Fresquet
Resources Table and Suppl. Tables. S1-S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c062deac21564ce858ab3b68ff8059
https://doi.org/10.1158/2159-8290.22540331
https://doi.org/10.1158/2159-8290.22540331
Autor:
Marta Larrayoz, Maria J. Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, Cesar Cobaleda, Cirino Botta, Vicente Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, P. Leif Bergsagel, Maria J. Larrayoz, Maria J. Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vicent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G. Katz, Loren D. Walensky, Shannon M. Ruppert, Elisabeth A. Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan J. Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Kudryashova, Anna Kurilovich, Maria V. Revuelta, Leandro Cerchietti, Xabier Agirre, Jesus San Miguel, Bruno Paiva, Felipe Prosper, Jose A. Martinez-Climent
The historical lack of preclinical models reflecting the genetic heterogeneity of multiple myeloma (MM) hampers the advance of therapeutic discoveries. To circumvent this limitation, we screened mice engineered to carry eight MM lesions (NF-κB, KRAS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2563a745972cadf6c4af5126546113b9
https://hdl.handle.net/10171/65914
https://hdl.handle.net/10171/65914
Autor:
Claudia Sargas, Rosa Ayala, María J. Larráyoz, María C. Chillón, Eduardo Rodriguez-Arboli, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan Bergua, Lorenzo Algarra, Mar Tormo, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan M. Alonso-Dominguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J. Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María J. Calasanz, Ramón García-Sanz, José A. Pérez-Simón, María T. Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, PETHEMA cooperative study group
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Next-Generation Sequencing is needed for the accurate genetic risk stratification of acute myeloid leukemia according to European LeukemiaNet (ELN) guidelines. We validated and compared the 2022 ELN risk classification in a real-life cohort
Externí odkaz:
https://doaj.org/article/922c45afad2e435b8c679c0aca4ae8f0
Autor:
Maria J, García-Barchino, Maria E, Sarasquete, Carlos, Panizo, Julie, Morscio, Antonio, Martinez, Miguel, Alcoceba, Vicente, Fresquet, Blanca, Gonzalez-Farre, Bruno, Paiva, Ken H, Young, Eloy F, Robles, Sergio, Roa, Jon, Celay, Marta, Larrayoz, Davide, Rossi, Gianluca, Gaidano, Santiago, Montes-Moreno, Miguel A, Piris, Ana, Balanzategui, Cristina, Jimenez, Idoia, Rodriguez, Maria J, Calasanz, Maria J, Larrayoz, Victor, Segura, Ricardo, Garcia-Muñoz, Maria P, Rabasa, Shuhua, Yi, Jianyong, Li, Mingzhi, Zhang, Zijun Y, Xu-Monette, Noemi, Puig-Moron, Alberto, Orfao, Sebastian, Böttcher, Jesus M, Hernandez-Rivas, Jesus San, Miguel, Felipe, Prosper, Thomas, Tousseyn, Xavier, Sagaert, Marcos, Gonzalez, Jose A, Martinez-Climent
Publikováno v:
The Journal of pathology. 245(1)
The increased risk of Richter transformation (RT) in patients with chronic lymphocytic leukaemia (CLL) due to Epstein-Barr virus (EBV) reactivation during immunosuppressive therapy with fludarabine other targeted agents remains controversial. Among 3
Autor:
Tamara Castaño-Bonilla, Juan M. Alonso-Dominguez, Eva Barragán, Rebeca Rodríguez-Veiga, Claudia Sargas, Cristina Gil, Carmen Chillón, María B. Vidriales, Raimundo García, Joaquín Martínez-López, Rosa Ayala, María J. Larrayoz, Eduardo Anguita, Rebeca Cuello, Alberto Cantalapiedra, Estrella Carrillo, Elena Soria-Saldise, Jorge Labrador, Isabel Recio, Lorenzo Algarra, Carlos Rodríguez-Medina, Cristina Bilbao-Syeiro, Juan A. López-López, Josefina Serrano, Erik De Cabo, María J. Sayas, María T. Olave, Joaquín Sánchez-García, Mamen Mateos, Carlos Blas, Jose L. López-Lorenzo, Daniel Lainez-Gonzalez, Juana Serrano, David Martínez-Cuadrón, Miguel A. Sanz, Pau Montesinos
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract FLT3-ITD mutations are detected in approximately 25% of newly diagnosed adult acute myeloid leukemia (AML) patients and confer an adverse prognosis. The FLT3-ITD allelic ratio has clear prognostic value. Nevertheless, there are numerous manu
Externí odkaz:
https://doaj.org/article/fdbb40702f114bf78acc458a1b88a71c
Autor:
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María J. Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao, Joaquín Sánchez-García, Teresa Bernal, David Martinez-Cuadron, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José A. Pérez-Simón, María Calbacho, Juan M. Alonso-Domínguez, Jorge Labrador, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María J. Calasanz, Teresa Gomez-Casares, Ramón García-Sanz, Miguel A. Sanz, Joaquín Martínez-López, Pau Montesinos
Publikováno v:
Cancers, Vol 14, Iss 23, p 5799 (2022)
FLT3–ITD results in a poor prognosis in terms of overall survival (OS) and relapse-free survival (RFS) in acute myeloid leukemia (AML). However, the prognostic usefulness of the allelic ratio (AR) to select post-remission therapy remains controvers
Externí odkaz:
https://doaj.org/article/2d904575ac5c43c29e7cd0b523c72739
Autor:
Claudia Sargas, Rosa Ayala, María Carmen Chillón, María J. Larráyoz, Estrella Carrillo-Cruz, Cristina Bilbao, Manuel Yébenes-Ramírez, Marta Llop, Inmaculada Rapado, Ramón García-Sanz, Iria Vázquez, Elena Soria, Yanira Florido-Ortega, Kamila Janusz, Carmen Botella, Josefina Serrano, David Martínez-Cuadrón, Juan Bergua, Mari Luz Amigo, Pilar Martínez-Sánchez, Mar Tormo, Teresa Bernal, Pilar Herrera-Puente, Raimundo García, Lorenzo Algarra, María J. Sayas, Lisette Costilla-Barriga, Esther Pérez-Santolalla, Inmaculada Marchante, Esperanza Lavilla-Rubira, Víctor Noriega, Juan M. Alonso-Domínguez, Miguel Á. Sanz, Joaquín Sánchez-Garcia, María T. Gómez-Casares, José A. Pérez-Simón, María J. Calasanz, Marcos González-Díaz, Joaquín Martínez-López, Eva Barragán, Pau Montesinos
Publikováno v:
Haematologica, Vol 106, Iss 12 (2020)
Next-generation sequencing (NGS) has recently been introduced to efficiently and simultaneously detect genetic variations in acute myeloid leukemia (AML). However, its implementation in the clinical routine raises new challenges focused on the divers
Externí odkaz:
https://doaj.org/article/96f8635ebc8f4c32bd95b017d0058695
Autor:
Eva Barragán, Pau Montesinos, Mireia Camos, Marcos González, Maria J. Calasanz, José Román-Gómez, Maria T. Gómez-Casares, Rosa Ayala, Javier López, Óscar Fuster, Dolors Colomer, Carmen Chillón, María J. Larrayoz, Pedro Sánchez-Godoy, José González-Campos, Félix Manso, Maria L. Amador, Edo Vellenga, Bob Lowenberg, Miguel A. Sanz
Publikováno v:
Haematologica, Vol 96, Iss 10 (2011)
Background Fms-like tyrosine kinase-3 (FLT3) gene mutations are frequent in acute promyelocytic leukemia but their prognostic value is not well established.Design and Methods We evaluated FLT3-internal tandem duplication and FLT3-D835 mutations in pa
Externí odkaz:
https://doaj.org/article/61645e85ddeb4ab1890368d26a4ce8fe